Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Special Drug Use Investigation of Xarelto [SPAF]

Next Previous
Trial Profile

Special Drug Use Investigation of Xarelto [SPAF]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Embolism; Myocardial infarction; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms XAPASS
  • Sponsors Bayer

    • Most Recent Events

    • 01 Sep 2020 Results (n=11,308 ) of sub-analysis of XAPASS assess long-term safety and effectiveness of reduced-dose rivaroxaban in high-risk NVAF patients for bleeding and thromboembolism presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
    • 03 Feb 2020 Status changed from active, no longer recruiting to completed.
    • 08 Feb 2019 One year follow-up results (n=9578) were presented at the International Stroke Conference 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top